首页   按分类浏览 期刊浏览 卷期浏览 Guidelines for Use of Azaribine in Treatment of Psoriasis
Guidelines for Use of Azaribine in Treatment of Psoriasis

 

作者:

 

期刊: Archives of Dermatology  (JAMA Available online 1976)
卷期: Volume 112, issue 3  

页码: 388-390

 

ISSN:0003-987X

 

年代: 1976

 

DOI:10.1001/archderm.1976.01630270058014

 

数据来源: JAMA

 

摘要:

Physicians contemplating the use of azaribine (Triazure) should become familiar with the chemistry, pharmacologic aspects, and toxic effects of the drug. Therefore, we strongly recommend that these guidelines be carefully studied before the drug is administered.DESCRIPTION GeneralAzaribine (2′, 3′, 5′-triacetyl-6-azauridine) is the orally absorbable triacetylated derivative of the pyrimidine analog 6-azauridine. It is a white, odorless, crystalline substance that is very insoluble in water. The structural formula of azaribine is presented in the Figure.Azaribine is supplied as white film-coated tablets, each containing 500 mg of azaribine (active ingredient) and the following excipients: starch (USP), calcium sulfate, gelatin, magnesium stearate (USP), and distilled water.Biochemical ActivityThe primary action of this compound is related to the activity of the nucleoside 6-azauridine, which is a structural analog of uridine. In mammalian systems, 6-azauridine, after its metabolic conversion to 6-azauridine-5′-phosphate, competitively inhibits intracellular pyrimidine nucleotide synthesis. The primary

 

点击下载:  PDF (353KB)



返 回